Luiz Bertassoni, D.D.S., Ph.D., shows an engineered material that replicates human bone tissue. The material is being used to explore disease processes such as the origin of metastatic tumors in bone, and as a treatment for large bone injuries. (OHSU/Joe Rojas-Burke)

Avathamsa Athirasala, M.Sc.Eng. (OHSU/Joe Rojas-Burke)

Luiz Bertassoni, D.D.S., Ph.D., shows an engineered material that replicates human bone tissue. The material is being used to explore disease processes such as the origin of metastatic tumors in bone, and as a treatment for large bone injuries. (OHSU/Joe Rojas-Burke)

Researchers at CEDAR, the Cancer Early Detection Advanced Research Center in the OHSU Knight Cancer Institute, have engineered material that replicates human bone tissue. The material is being used to explore disease processes such as the origin of metastatic tumors in bone, and as a treatment for large bone injuries. (OHSU/Joe Rojas-Burke)

Avathamsa Athirasala, M.Sc.Eng. (left) and Luiz Bertassoni, D.D.S., Ph.D. (OHSU/Joe Rojas-Burke)

Trial participant Bill Westmoreland takes part in a class in July 2019 at OHSU. The class is part of a NIH-funded clinical trial testing two types of exercise--tai chi versus strength training--as a means to prevent falls and injuries in men who've received anti-androgen therapy for prostate cancer. (OHSU/Joe Rojas-Burke)

Brian Fawkes, trial participant, (left) is guided by trainer Kimi Daniel during a class in July 2019 at OHSU. The class is part of a NIH-funded clinical trial testing two types of exercise--tai chi versus strength training--as a means to prevent falls and injuries in men who've received anti-androgen therapy for prostate cancer. (OHSU/Joe Rojas-Burke)

Jacklien Shannon, Ph.D., R.D.

Gordon Mills, M.D., Ph.D., at the Knight Cancer Research Center in Portland, September 13, 2018. (OHSU/John Valls)

Gordon Mills, M.D., Ph.D.